Lincoln Pharmaceuticals has unveiled an Ondansetron oral spray, used for treatment of nausea and vomiting caused by surgery or cancer drugs, in the Indian market. The company has done bio-equivalent study for Ondansetron oral spray and has got the Drug Controller General of India (DCGI) permission. Ondansetron was earlier available as tablet, syrup and injectable in India. All India level the Anti-emetic drug market is Rs 678 crore and Ondansetron is one of the anti-emetic drug and all over India market is Rs 303 crore. Therefore, Ondansetron Spray is having very good market opportunity.
Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: